# Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy

> **NCT01796418** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 102 (estimated)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Beraprost sodium

## Key facts

- **NCT ID:** NCT01796418
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2014-08
- **Final completion:** —
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2013-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796418, "Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01796418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*